✨ Free AI Report
Euroapi S.A.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Euroapi S.A.
Company Research

Euroapi S.A.: Business Overview, Financials & Competitive Analysis

Euroapi S.A. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Specialized API provider with European heritage facing transitional headwinds, recovery dependent on CDMO growth and operational discipline. Euroapi holds a defensible market position as a specialized API and CDMO provider with strategic geographic footprint across Europe and North America. However, recent earnings show declining sales and mounting profitability pressures, reflecting.

What is Euroapi S.A.'s industry? Euroapi S.A. (euroapi.com) operates in Pharmaceuticals - Active Pharmaceutical Ingredients (APIs) and Contract Development Manufacturing Organization (CDMO). AskCyborg classifies Euroapi S.A. under Pharmaceuticals - Active Pharmaceutical Ingredients (APIs) and Contract Development Manufacturing Organization (CDMO) in its company registry.

Euroapi develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, a...

5/ 10Mixed

Cyborg Score thesis

Specialized API provider with European heritage facing transitional headwinds, recovery dependent on CDMO growth and operational...

Read the full analyst-debate transcript →
Industry Pharmaceuticals - Active Pharmaceutical Ingredients (APIs) and Contract Development Manufacturing Organization (CDMO)
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Euroapi S.A. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Euroapi S.A.

AskCyborg analysts argue the bull and bear cases for Euroapi S.A. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Euroapi S.A. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Euroapi S.A. Overview

Pro stress-test →

Euroapi develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company operates six production sites across Europe and provides both standard products and Contract Development Manufacturing Organization (CDMO) services to a diverse customer base including pharmaceutical companies, biotech firms, and cosmetic manufacturers.

Strategic Profile

Pro stress-test →

The company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world. The company has a strategic alliance with Abolis Biotechnologies SAS for the development of microbial strains for the synthesis of key intermediates and 20 active ingredients, positioning it as a specialized player in high-complexity pharmaceutical ingredient manufacturing with growing biotechnology integration.

Competitive Landscape

Pro stress-test →

Euroapi competes in the global API and CDMO market against larger integrated pharmaceutical manufacturers and specialized API providers. Key competitive dynamics include price pressure on commodity APIs, consolidation in the industry, and increasing demand for complex molecule manufacturing. The company's European manufacturing footprint and specialist capabilities provide differentiation but face pressure from Asian competitors and larger CDMOs.

Industry Context

Euroapi S.A. operates in Pharmaceuticals - Active Pharmaceutical Ingredients (APIs) and Contract Development Manufacturing Organization (CDMO).

Key facts

Founded: 2020 · Headquarters: Lisses, France · Market cap: €135.77M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Euroapi S.A..

  • European API market leader with diversified product portfolio including vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids, hormones, and opiates
  • Stock trading at €1.25 as of March 28, 2026, down significantly from 52-week high of €3.57, indicating investor concerns about business fundamentals
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Earnings call highlighted declining sales trends with focus on operational discipline
  • 2025Maintained strategic biotechnology partnership with Abolis Biotechnologies
  • +1 moreTrack every material event for Euroapi S.A. as it happens. Explore monitoring →
Get alerted when Euroapi S.A. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

WuXi AppTecLarge integrated CDMO and API provider with Asian manufacturing base→LonzaGlobal pharmaceutical manufacturing and CDMO services provider→CatalentAdvanced delivery and CDMO solutions for pharmaceutical and biotech industries→ViatrisGenerics manufacturer with API and pharmaceutical intermediate operations→

Compare Euroapi S.A. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Euroapi S.A. operates in Pharmaceuticals - Active Pharmaceutical Ingredients (APIs) and Contract Development Manufacturing Organization (CDMO). See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals - Active Pharmaceutical Ingredients (APIs) and Contract Development Manufacturing Organization (CDMO) research →
NEW · MCP server

Ask your AI assistant about Euroapi S.A.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Euroapi S.A. and its top competitor on Cyborg Score”
“What did Euroapi S.A. do this quarter?”
“Is Euroapi S.A. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Euroapi S.A. do?+
Euroapi develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, a...
What is Euroapi S.A.'s Cyborg Score?+
Euroapi S.A. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Euroapi S.A.'s main competitors?+
Named competitors include WuXi AppTec, Lonza, Catalent, Viatris. The full competitive landscape is in the AskCyborg report.
How can I get the full Euroapi S.A. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Euroapi S.A. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Euroapi S.A. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals - Active Pharmaceutical Ingredients (APIs) and Contract Development Manufacturing Organization (CDMO) research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Lonza Group AG7Viatris Inc.